Publications

Carolyn Anderson

Roy R, Hahm ER, White AG, Anderson CJ, Singh SV. AKT-dependent sugar addiction by benzyl isothiocyanate in breast cancer cells. Mol Carcinog. 2019 Jun;58(6):996-1007. doi: 10.1002/mc.22988. PubMed PMID: 30720225; PMCID: PMC6525032.
Lux F, Tran VL, Thomas E, Dufort S, Rossetti F, Martini M, Truillet C, Doussineau T, Bort G, Denat F, Boschetti F, Angelovski G, Detappe A, Crémillieux Y, Mignet N, Doan BT, Larrat B, Meriaux S, Barbier E, Roux S, Fries P, Müller A, Abadjian MC, Anderson C, Canet-Soulas E, Bouziotis P, Barberi-Heyob M, Frochot C, Verry C, Balosso J, Evans M, Sidi-Boumedine J, Janier M, Butterworth K, McMahon S, Prise K, Aloy MT, Ardail D, Rodriguez-Lafrasse C, Porcel E, Lacombe S, Berbeco R, Allouch A, Perfettini JL, Chargari C, Deutsch E, Le Duc G, Tillement O. AGuIX® from bench to bedside-Transfer of an ultrasmall theranostic gadolinium-based nanoparticle to clinical medicine. Br J Radiol. 2018 Sep 18;20180365. doi: 10.1259/bjr.20180365. PubMed PMID: 30226413; PMCID: PMC6435081.
Choi J, Beaino W, Fecek RJ, Fabian KPL, Laymon CM, Kurland BF, Storkus WJ, Anderson CJ. Combined VLA-4-Targeted Radionuclide Therapy and Immunotherapy in a Mouse Model of Melanoma. J Nucl Med. 2018 Dec;59(12):1843-1849. doi: 10.2967/jnumed.118.209510. PubMed PMID: 29959213; PMCID: PMC6278902.
Tolmachev V, Grönroos TJ, Yim CB, Garousi J, Yue Y, Grimm S, Rajander J, Perols A, Haaparanta-Solin M, Solin O, Ferdani R, Orlova A, Anderson CJ, Karlström AE. Molecular design of radiocopper-labelled Affibody molecules. Sci Rep. 2018 Apr 25;8(1):6542. doi: 10.1038/s41598-018-24785-2. PubMed PMID: 29695813; PMCID: PMC5916907.
Ocak M, Beaino W, White A, Zeng D, Cai Z, Anderson CJ. 64Cu-Labeled Phosphonate Cross-Bridged Chelator Conjugates of c(RGDyK) for PET/CT Imaging of Osteolytic Bone Metastases. Cancer Biother Radiopharm. 2018 Mar;33(2):74-83. doi: 10.1089/cbr.2017.2419. PubMed PMID: 29634417; PMCID: PMC5865263.
Dai L, Jones CM, Chan WTK, Pham TA, Ling X, Gale EM, Rotile NJ, Tai WC, Anderson CJ, Caravan P, Law GL. Chiral DOTA chelators as an improved platform for biomedical imaging and therapy applications. Nat Commun. 2018 Feb 27;9(1):857. doi: 10.1038/s41467-018-03315-8. PubMed PMID: 29487362; PMCID: PMC5829242.
Abadjian MZ, Edwards WB, Anderson CJ. Imaging the Tumor Microenvironment. Adv Exp Med Biol. 2017;1036229-257. doi: 10.1007/978-3-319-67577-0_15. PubMed PMID: 29275475.
Pore SK, Hahm ER, Latoche JD, Anderson CJ, Shuai Y, Singh SV. Prevention of breast cancer-induced osteolytic bone resorption by benzyl isothiocyanate. Carcinogenesis. 2018 Feb 9;39(2):134-145. doi: 10.1093/carcin/bgx114. PubMed PMID: 29040431; PMCID: PMC5862255.
Anderson CJ, Lewis JS. Current status and future challenges for molecular imaging. Philos Trans A Math Phys Eng Sci. 2017 Nov 28;375(2107): doi: 10.1098/rsta.2017.0023. PubMed PMID: 29038378.
Kikuchi M, Clump DA, Srivastava RM, Sun L, Zeng D, Diaz-Perez JA, Anderson CJ, Edwards WB, Ferris RL. Preclinical immunoPET/CT imaging using Zr-89-labeled anti-PD-L1 monoclonal antibody for assessing radiation-induced PD-L1 upregulation in head and neck cancer and melanoma. Oncoimmunology. 2017;6(7):e1329071. doi: 10.1080/2162402X.2017.1329071. PubMed PMID: 28811971; PMCID: PMC5543907.
Demirci E, Ahmed R, Ocak M, Latoche J, Radelet A, DeBlasio N, Mason NS, Anderson CJ, Mountz JM. Preclinical Evaluation of 18F-ML-10 to Determine Timing of Apoptotic Response to Chemotherapy in Solid Tumors. Mol Imaging. 2017 Jan 1;161536012116685941. doi: 10.1177/1536012116685941. PubMed PMID: 28654376; PMCID: PMC5469516.
Choy CJ, Ling X, Geruntho JJ, Beyer SK, Latoche JD, Langton-Webster B, Anderson CJ, Berkman CE. 177Lu-Labeled Phosphoramidate-Based PSMA Inhibitors: The Effect of an Albumin Binder on Biodistribution and Therapeutic Efficacy in Prostate Tumor-Bearing Mice. Theranostics. 2017;7(7):1928-1939. doi: 10.7150/thno.18719. PubMed PMID: 28638478; PMCID: PMC5479279.
Gai Y, Sun L, Hui W, Ouyang Q, Anderson CJ, Xiang G, Ma X, Zeng D. New Bifunctional Chelator p-SCN-PhPr-NE3TA for Copper-64: Synthesis, Peptidomimetic Conjugation, Radiolabeling, and Evaluation for PET Imaging. Inorg Chem. 2016 Jul 18;55(14):6892-901. doi: 10.1021/acs.inorgchem.6b00395. PubMed PMID: 27347690; PMCID: PMC4949121.
Kim SH, Hahm ER, Arlotti JA, Samanta SK, Moura MB, Thorne SH, Shuai Y, Anderson CJ, White AG, Lokshin A, Lee J, Singh SV. Withaferin A inhibits in vivo growth of breast cancer cells accelerated by Notch2 knockdown. Breast Cancer Res Treat. 2016 May;157(1):41-54. doi: 10.1007/s10549-016-3795-y. PubMed PMID: 27097807; PMCID: PMC4867258.
Soodgupta D, Zhou H, Beaino W, Lu L, Rettig M, Snee M, Skeath J, DiPersio JF, Akers WJ, Laforest R, Anderson CJ, Tomasson MH, Shokeen M. Ex Vivo and In Vivo Evaluation of Overexpressed VLA-4 in Multiple Myeloma Using LLP2A Imaging Agents. J Nucl Med. 2016 Apr;57(4):640-5. doi: 10.2967/jnumed.115.164624. PubMed PMID: 26742713; PMCID: PMC4887080.
Cai Z, Mason NS, Anderson CJ, Edwards WB. Synthesis and preliminary evaluation of an ¹⁸F-labeled oleic acid analog for PET imaging of fatty acid uptake and metabolism. Nucl Med Biol. 2016 Jan;43(1):108-115. doi: 10.1016/j.nucmedbio.2015.08.005. PubMed PMID: 26602329.
Nedrow JR, Latoche JD, Day KE, Modi J, Ganguly T, Zeng D, Kurland BF, Berkman CE, Anderson CJ. Targeting PSMA with a Cu-64 Labeled Phosphoramidate Inhibitor for PET/CT Imaging of Variant PSMA-Expressing Xenografts in Mouse Models of Prostate Cancer. Mol Imaging Biol. 2016 Jun;18(3):402-10. doi: 10.1007/s11307-015-0908-7. PubMed PMID: 26552656.
Sun L, Gai Y, Anderson CJ, Zeng D. Highly-efficient and versatile fluorous-tagged Cu(I)-catalyzed azide-alkyne cycloaddition ligand for preparing bioconjugates. Chem Commun (Camb). 2015 Dec 14;51(96):17072-5. doi: 10.1039/c5cc06858d. PubMed PMID: 26426419; PMCID: PMC4654650.
Song J, Cai Z, White AG, Jin T, Wang X, Kadayakkara D, Anderson CJ, Ambrose Z, Young WB. Visualization and quantification of simian immunodeficiency virus-infected cells using non-invasive molecular imaging. J Gen Virol. 2015 Oct;96(10):3131-42. doi: 10.1099/jgv.0.000245. PubMed PMID: 26297664; PMCID: PMC4857449.
Zhang S, Shao P, Ling X, Yang L, Hou W, Thorne SH, Beaino W, Anderson CJ, Ding Y, Bai M. In vivo inflammation imaging using a CB2R-targeted near infrared fluorescent probe. Am J Nucl Med Mol Imaging. 2015;5(3):246-58. PubMed PMID: 26069858; PMCID: PMC4446393.
Patel SK, Beaino W, Anderson CJ, Janjic JM. Theranostic nanoemulsions for macrophage COX-2 inhibition in a murine inflammation model. Clin Immunol. 2015 Sep;160(1):59-70. doi: 10.1016/j.clim.2015.04.019. PubMed PMID: 25959685; PMCID: PMC4554801.
Beaino W, Nedrow JR, Anderson CJ. Evaluation of (68)Ga- and (177)Lu-DOTA-PEG4-LLP2A for VLA-4-Targeted PET Imaging and Treatment of Metastatic Melanoma. Mol Pharm. 2015 Jun 1;12(6):1929-38. doi: 10.1021/mp5006917. PubMed PMID: 25919487; PMCID: PMC5167571.
Shakir M, Tang D, Zeh HJ, Tang SW, Anderson CJ, Bahary N, Lotze MT. The chemokine receptors CXCR4/CXCR7 and their primary heterodimeric ligands CXCL12 and CXCL12/high mobility group box 1 in pancreatic cancer growth and development: finding flow. Pancreas. 2015 May;44(4):528-34. doi: 10.1097/MPA.0000000000000298. PubMed PMID: 25872129.
Cai Z, Li BT, Wong EH, Weisman GR, Anderson CJ. Cu(I)-assisted click chemistry strategy for conjugation of non-protected cross-bridged macrocyclic chelators to tumour-targeting peptides. Dalton Trans. 2015 Mar 7;44(9):3945-8. doi: 10.1039/c4dt03897e. PubMed PMID: 25645688; PMCID: PMC5200953.
Lux J, White AG, Chan M, Anderson CJ, Almutairi A. Nanogels from metal-chelating crosslinkers as versatile platforms applied to copper-64 PET imaging of tumors and metastases. Theranostics. 2015;5(3):277-88. doi: 10.7150/thno.10904. PubMed PMID: 25553115; PMCID: PMC4279191.
Beaino W, Anderson CJ. PET imaging of very late antigen-4 in melanoma: comparison of 68Ga- and 64Cu-labeled NODAGA and CB-TE1A1P-LLP2A conjugates. J Nucl Med. 2014 Nov;55(11):1856-63. doi: 10.2967/jnumed.114.144881. PubMed PMID: 25256059; PMCID: PMC4277817.
Cai Z, Ouyang Q, Zeng D, Nguyen KN, Modi J, Wang L, White AG, Rogers BE, Xie XQ, Anderson CJ. 64Cu-labeled somatostatin analogues conjugated with cross-bridged phosphonate-based chelators via strain-promoted click chemistry for PET imaging: in silico through in vivo studies. J Med Chem. 2014 Jul 24;57(14):6019-29. doi: 10.1021/jm500416f. PubMed PMID: 24983404; PMCID: PMC4261236.
Zeng D, Guo Y, White AG, Cai Z, Modi J, Ferdani R, Anderson CJ. Comparison of conjugation strategies of cross-bridged macrocyclic chelators with cetuximab for copper-64 radiolabeling and PET imaging of EGFR in colorectal tumor-bearing mice. Mol Pharm. 2014 Nov 3;11(11):3980-7. doi: 10.1021/mp500004m. PubMed PMID: 24720806; PMCID: PMC4224567.

<< Investigators Search

Top